Literature DB >> 12540166

Identification of hypoglycemia in mice as a surrogate marker of ricin toxicosis.

Seth H Pincus1, Leta Eng, Corrie L Cooke, Massimo Maddaloni.   

Abstract

PURPOSE: In an effort to develop a non-lethal model of ricin toxicosis, we studied the biochemical effects of the administration of ricin in mice.
METHODS: Mice received an intraperitoneal injection of ricin toxin, after which a panel of 21 biochemical parameters was determined. Effect of ricin administration on blood glucose concentration was studied in greater detail. To determine whether results of biochemical analyses correlated with therapeutic manipulations known to protect against ricin toxicosis, the effect of immunization on blood glucose values after ricin administration was studied.
RESULTS: Of the biochemical parameters studied, only blood glucose and amylase values were affected by ricin administration. Because blood glucose concentration can be easily and instantaneously measured on 25 to 50 microl of blood, using handheld instruments, this parameter was further evaluated. A dose- and time-related decrease in blood glucose concentration was documented. Mice immunized with ricin had smaller changes in blood glucose concentration than did non-immunized animals after ricin administration.
CONCLUSION: Blood glucose concentration may be used as a surrogate for lethal challenge as a measure of ricin toxicosis after its systemic administration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12540166

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  23 in total

1.  Animal models of ricin toxicosis.

Authors:  Chad J Roy; Kejing Song; Satheesh K Sivasubramani; Donald J Gardner; Seth H Pincus
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

2.  RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Authors:  Joan E Smallshaw; James A Richardson; Ellen S Vitetta
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

3.  Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin.

Authors:  David J Vance; Jacqueline M Tremblay; Nicholas J Mantis; Charles B Shoemaker
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

4.  Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.

Authors:  Joanne M O'Hara; Robert N Brey; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

5.  Chimeric plantibody passively protects mice against aerosolized ricin challenge.

Authors:  Erin K Sully; Kevin J Whaley; Natasha Bohorova; Ognian Bohorov; Charles Goodman; Do H Kim; Michael H Pauly; Jesus Velasco; Ernie Hiatt; Josh Morton; Kelsi Swope; Chad J Roy; Larry Zeitlin; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

6.  Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit.

Authors:  Joanne M O'Hara; Kevin Whaley; Michael Pauly; Larry Zeitlin; Nicholas J Mantis
Journal:  Vaccine       Date:  2011-12-22       Impact factor: 3.641

7.  Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB).

Authors:  Anastasiya Yermakova; Nicholas J Mantis
Journal:  Vaccine       Date:  2011-08-26       Impact factor: 3.641

8.  Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.

Authors:  Kimberly J Hassett; Megan C Cousins; Lilia A Rabia; Chrystal M Chadwick; Joanne M O'Hara; Pradyot Nandi; Robert N Brey; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2013-04-10       Impact factor: 5.571

9.  Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments.

Authors:  Anastasiya Yermakova; Nicholas J Mantis
Journal:  Toxicon       Date:  2013-04-17       Impact factor: 3.033

10.  A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin.

Authors:  Lori M Neal; Joanne O'Hara; Robert N Brey; Nicholas J Mantis
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.